Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group IND.190 -- A Phase I-II Trial of MK-0646, A Monoclonal Antibody Against Insulin-Like Growth Factor-1 Receptor in Combination with Etoposide and Cisplatin in Extensive Stage Small Cell Lung Cancer -- was centrally activated 30 January 2009.
http://www.ctg.queensu.ca/trials/ind/i190/190.html